Cargando…
Indirect costs of rheumatoid arthritis
It is estimated that in Poland about 400,000 persons in general suffer from inflammatory joint diseases, including rheumatoid arthritis (RA). Epidemiological surveys documenting the frequency and disturbance of musculoskeletal disorders in the Polish population are few in number. Most of the estimat...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4847321/ https://www.ncbi.nlm.nih.gov/pubmed/27407258 http://dx.doi.org/10.5114/reum.2015.55830 |
_version_ | 1782429192622702592 |
---|---|
author | Raciborski, Filip Kłak, Anna Kwiatkowska, Brygida |
author_facet | Raciborski, Filip Kłak, Anna Kwiatkowska, Brygida |
author_sort | Raciborski, Filip |
collection | PubMed |
description | It is estimated that in Poland about 400,000 persons in general suffer from inflammatory joint diseases, including rheumatoid arthritis (RA). Epidemiological surveys documenting the frequency and disturbance of musculoskeletal disorders in the Polish population are few in number. Most of the estimations are based on epidemiological data from other countries (prevalence of 0.5–1%). According to the data of the National Health Fund in Poland 135,000–157,000 persons in total are treated because of rheumatoid arthritis per year [ICD10 (International Statistical Classification of Diseases and Related Health Problems): M05, M06]. In the case of this group of diseases indirect costs significantly outweigh the direct costs. Indirect costs increase together with activity level of the disease. The cost analysis of productivity loss of RA patients indicates that sickness absenteeism and informal care are the most burdensome. At the national level it amounts in total from 1.2 billion to 2.8 billion PLN per year, depending on the method of analysis. These costs could be significantly reduced through early diagnosis and introduction of effective treatment. |
format | Online Article Text |
id | pubmed-4847321 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie |
record_format | MEDLINE/PubMed |
spelling | pubmed-48473212016-07-12 Indirect costs of rheumatoid arthritis Raciborski, Filip Kłak, Anna Kwiatkowska, Brygida Reumatologia Review Paper It is estimated that in Poland about 400,000 persons in general suffer from inflammatory joint diseases, including rheumatoid arthritis (RA). Epidemiological surveys documenting the frequency and disturbance of musculoskeletal disorders in the Polish population are few in number. Most of the estimations are based on epidemiological data from other countries (prevalence of 0.5–1%). According to the data of the National Health Fund in Poland 135,000–157,000 persons in total are treated because of rheumatoid arthritis per year [ICD10 (International Statistical Classification of Diseases and Related Health Problems): M05, M06]. In the case of this group of diseases indirect costs significantly outweigh the direct costs. Indirect costs increase together with activity level of the disease. The cost analysis of productivity loss of RA patients indicates that sickness absenteeism and informal care are the most burdensome. At the national level it amounts in total from 1.2 billion to 2.8 billion PLN per year, depending on the method of analysis. These costs could be significantly reduced through early diagnosis and introduction of effective treatment. Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie 2015-12-08 2015 /pmc/articles/PMC4847321/ /pubmed/27407258 http://dx.doi.org/10.5114/reum.2015.55830 Text en Copyright © Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie 2015 http://creativecommons.org/licenses/by-nc-sa/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license. |
spellingShingle | Review Paper Raciborski, Filip Kłak, Anna Kwiatkowska, Brygida Indirect costs of rheumatoid arthritis |
title | Indirect costs of rheumatoid arthritis |
title_full | Indirect costs of rheumatoid arthritis |
title_fullStr | Indirect costs of rheumatoid arthritis |
title_full_unstemmed | Indirect costs of rheumatoid arthritis |
title_short | Indirect costs of rheumatoid arthritis |
title_sort | indirect costs of rheumatoid arthritis |
topic | Review Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4847321/ https://www.ncbi.nlm.nih.gov/pubmed/27407258 http://dx.doi.org/10.5114/reum.2015.55830 |
work_keys_str_mv | AT raciborskifilip indirectcostsofrheumatoidarthritis AT kłakanna indirectcostsofrheumatoidarthritis AT kwiatkowskabrygida indirectcostsofrheumatoidarthritis |